This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Laughlin, G. A. Articles by Bergstrom, J. Search for Related Content PubMed PubMed Citation Articles by Laughlin, G. A. Articles by Bergstrom, J. Related Collections Male Endocrinology

Low Serum Testosterone and Mortality in Older Men

Department of Family and Preventive Medicine, School of Medicine, University of California, San Diego, La Jolla, California 92093

Address all correspondence and requests for reprints to: Gail A. Laughlin, Ph.D., Department of Family and Preventive Medicine, School of Medicine, University of California, San Diego, 9500 Gilman Drive, MC 0631C, La Jolla, California 92093. E-mail: glaughlin{at}ucsd.edu.

Context: Declining testosterone levels in elderly men are thought to underlie many of the symptoms and diseases of aging; however, studies demonstrating associations of low testosterone with clinical outcomes are few.

Objective: The objective of the study was to examine the association of endogenous testosterone levels with mortality in older community-dwelling men.

Design, Setting, and Participants: This was a prospective, population-based study of 794 men, aged 50–91 (median 73.6) yr who had serum testosterone measurements at baseline (1984–1987) and were followed for mortality through July 2004.

Main Outcome Measure: All-cause mortality by serum testosterone level was measured.

Results: During an average 11.8-yr follow-up, 538 deaths occurred. Men whose total testosterone levels were in the lowest quartile (<241 ng/dl) were 40% [hazards ratio (HR) 1.40; 95% confidence interval (CI) 1.14–1.71] more likely to die than those with higher levels, independent of age, adiposity, and lifestyle. Additional adjustment for health status markers, lipids, lipoproteins, blood pressure, glycemia, adipocytokines, and estradiol levels had minimal effect on results. The low testosterone-mortality association was also independent of the metabolic syndrome, diabetes, and prevalent cardiovascular disease but was attenuated by adjustment for IL-6 and C-reactive protein. In cause-specific analyses, low testosterone predicted increased risk of cardiovascular (HR 1.38; 95% CI 1.02–1.85) and respiratory disease (HR 2.29; 95% CI 1.25–4.20) mortality but was not significantly related to cancer death (HR 1.34; 95% CI 0.89–2.00). Results were similar for bioavailable testosterone.

Conclusions: Testosterone insufficiency in older men is associated with increased risk of death over the following 20 yr, independent of multiple risk factors and several preexisting health conditions.

This article has been cited by other articles:

				B. B Yeap, S A P. Chubb, Z. Hyde, K. Jamrozik, G. J Hankey, L. Flicker, and P. E Norman Lower serum testosterone is independently associated with insulin resistance in non-diabetic older men: the Health In Men Study Eur. J. Endocrinol., October 1, 2009; 161(4): 591 - 598. [Abstract] [Full Text] [PDF]

				G. I Hackett, N. S Cole, A. A Deshpande, M. D Popple, D. Kennedy, and P. Wilkinson Biochemical hypogonadism in men with type 2 diabetes in primary care practice The British Journal of Diabetes & Vascular Disease, September 1, 2009; 9(5): 226 - 231. [Abstract] [PDF]

				T. Vikan, H. Schirmer, I. Njolstad, and J. Svartberg Endogenous sex hormones and the prospective association with cardiovascular disease and mortality in men: the Tromso Study Eur. J. Endocrinol., September 1, 2009; 161(3): 435 - 442. [Abstract] [Full Text] [PDF]

				A. Mathur, C. Malkin, B. Saeed, R Muthusamy, T H. Jones, and K. Channer Long-term benefits of testosterone replacement therapy on angina threshold and atheroma in men Eur. J. Endocrinol., September 1, 2009; 161(3): 443 - 449. [Abstract] [Full Text] [PDF]

				A. M. Traish, F. Saad, R. J. Feeley, and A. Guay The Dark Side of Testosterone Deficiency: III. Cardiovascular Disease J Androl, September 1, 2009; 30(5): 477 - 494. [Abstract] [Full Text] [PDF]

				B. B. Yeap, Z. Hyde, O. P. Almeida, P. E. Norman, S. A. P. Chubb, K. Jamrozik, L. Flicker, and G. J. Hankey Lower Testosterone Levels Predict Incident Stroke and Transient Ischemic Attack in Older Men J. Clin. Endocrinol. Metab., July 1, 2009; 94(7): 2353 - 2359. [Abstract] [Full Text] [PDF]

				A. Tivesten, L. Vandenput, F. Labrie, M. K. Karlsson, O. Ljunggren, D. Mellstrom, and C. Ohlsson Low Serum Testosterone and Estradiol Predict Mortality in Elderly Men J. Clin. Endocrinol. Metab., July 1, 2009; 94(7): 2482 - 2488. [Abstract] [Full Text] [PDF]

				H. S. Haugnes, N. Aass, S. D. Fossa, O. Dahl, M. Brydoy, U. Aasebo, T. Wilsgaard, and R. M. Bremnes Pulmonary Function in Long-Term Survivors of Testicular Cancer J. Clin. Oncol., June 10, 2009; 27(17): 2779 - 2786. [Abstract] [Full Text] [PDF]

				A. Theodoraki and P.-M. Bouloux Testosterone therapy in men Menopause Int, June 1, 2009; 15(2): 87 - 92. [Abstract] [Full Text] [PDF]

				M. Yaron, Y. Greenman, J. B Rosenfeld, E. Izkhakov, R. Limor, E. Osher, G. Shenkerman, K. Tordjman, and N. Stern Effect of testosterone replacement therapy on arterial stiffness in older hypogonadal men Eur. J. Endocrinol., May 1, 2009; 160(5): 839 - 846. [Abstract] [Full Text] [PDF]

				J. Svartberg, S. K Braekkan, G. A Laughlin, and J.-B. Hansen Endogenous sex hormone levels in men are not associated with risk of venous thromboembolism: the Tromso study Eur. J. Endocrinol., May 1, 2009; 160(5): 833 - 838. [Abstract] [Full Text] [PDF]

				J.-J. Legros, E. J H Meuleman, J. M H Elbers, T B P. Geurts, M. J G H Kaspers, P. M G Bouloux, and for the Study 43203 Investigators Oral testosterone replacement in symptomatic late-onset hypogonadism: effects on rating scales and general safety in a randomized, placebo-controlled study Eur. J. Endocrinol., May 1, 2009; 160(5): 821 - 831. [Abstract] [Full Text] [PDF]

				J. J. Carrero, A. R. Qureshi, P. Parini, S. Arver, B. Lindholm, P. Barany, O. Heimburger, and P. Stenvinkel Low Serum Testosterone Increases Mortality Risk among Male Dialysis Patients J. Am. Soc. Nephrol., March 1, 2009; 20(3): 613 - 620. [Abstract] [Full Text] [PDF]

				T H. Jones Late onset hypogonadism BMJ, February 13, 2009; 338(feb13_1): b352 - b352. [Full Text]

				G. Jackson CHAPTER 15c Erectile Dysfunction ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter. [Abstract] [Full Text]

				D. Rice, R. E. Brannigan, R. K. Campbell, S. Fine, L. Jack Jr, J. B. Nelson, and J. Regan-Klich Men's Health, Low Testosterone, and Diabetes: Individualized Treatment and a Multidisciplinary Approach The Diabetes Educator, November 1, 2008; 34(5_suppl): 97S - 112S. [Abstract] [Full Text] [PDF]

				A. Chandel, S. Dhindsa, S. Topiwala, A. Chaudhuri, and P. Dandona Testosterone Concentration in Young Patients With Diabetes Diabetes Care, October 1, 2008; 31(10): 2013 - 2017. [Abstract] [Full Text] [PDF]

				I. Peter, A. Kelley-Hedgepeth, C. S. Fox, L. Adrienne Cupples, G. S. Huggins, D. E. Housman, R. H. Karas, M. E. Mendelsohn, D. Levy, and J. M. Murabito Variation in Estrogen-Related Genes Associated with Cardiovascular Phenotypes and Circulating Estradiol, Testosterone, and Dehydroepiandrosterone Sulfate Levels J. Clin. Endocrinol. Metab., July 1, 2008; 93(7): 2779 - 2785. [Abstract] [Full Text] [PDF]

				E. A. Platz Low Testosterone and Risk of Premature Death in Older Men: Analytical and Preanalytical Issues in Measuring Circulating Testosterone Clin. Chem., July 1, 2008; 54(7): 1110 - 1112. [Full Text] [PDF]